THE LATEST IN WOMEN’S HEALTH
Capabilities for Clinical Studies in Female Sexual Dysfunction
Danielle Kroft
2018-12-11T19:59:01-05:00
Capabilities for Clinical Studies in the Genitourinary Syndrome of Menopause (GSM)
Danielle Kroft
2019-03-06T20:33:03-05:00
WHAT WE DO
Health Decisions is a full-service CRO providing extensive clinical development expertise and comprehensive services for bringing women’s health and diagnostics to market rapidly, efficiently and with minimal risk.
SERVICES
Trial Management
Trial Management
Health Decisions provides proactive project management for phase 1 – 4 trials of women’s health drugs as well as trials of devices and diagnostics for all therapeutic areas.
Monitoring
Monitoring
Health Decisions utilizes a monitoring approach based on team-work between field and in-house CRAs that ensures high data-quality and improves site performance.
Data and Quality Management
Data and Quality Management
The experienced Health Decisions data management and quality management groups ensure collection and delivery of high-quality data for each study.
Biostatistics
Biostatistics
Health Decisions’ biostatisticians provide statistical planning, design, programming and analysis to ensure that each study meets informational goals.
Study Design and Protocol Development
Study Design and Protocol Development
The Health Decisions biostatistical and clinical teams have extensive expertise in protocol development for phase 1 – 4 trials of therapeutics as well as for diagnostics trials.
Consulting
Consulting
Health Decisions’ experts provide medical, biostatistical, operational and regulatory consulting services to assist sponsors at every stage of clinical development.
BUILDING THE WORLD’S LEADING CRO IN WOMEN’S HEALTH AND DIAGNOSTICS
“Health Decisions is committed to building the world’s leading CRO in women’s health and diagnostics. We have collaborated effectively with many innovative sponsors of women’s health and diagnostic products. Our leadership team and clinical development experts are truly passionate about improving women’s health and interested in learning how we can bring your product to market rapidly with minimal cost and risk. We are equally passionate about assisting diagnostics developers in efficiently demonstrating the clinical validity and utility of their products.” Patrick Phillips, BSc (Hons), D.Phil., Chief Executive Officer
What Women’s Health Means to Us
The Importance of Diagnostics to Health Decisions
- Health Decisions to Participate in Important Reproductive Medicine Meeting healthdec_rljyp3 2017-09-26T18:31:25-05:00
Health Decisions to Participate in Important Reproductive Medicine Meeting
- CRO Health Decisions Joins Triangle Corporate Volunteer Council healthdec_rljyp3 2017-09-26T18:30:29-05:00
CRO Health Decisions Joins Triangle Corporate Volunteer Council
- Health Decisions Named to 2017 Training Top 125 Danielle Kroft 2017-10-03T21:37:55-05:00
Health Decisions Named to 2017 Training Top 125
- Health Decisions Attends Key Meeting on Women’s Sexual Health Danielle Kroft 2017-10-03T21:37:45-05:00
Health Decisions Attends Key Meeting on Women’s Sexual Health
- CRO Health Decisions Exhibits and Presents at DIA 2017 Danielle Kroft 2017-10-03T21:36:07-05:00
CRO Health Decisions Exhibits and Presents at DIA 2017
- CRO Health Decisions Names Andrea Lukes, MD, FACOG, CMO Danielle Kroft 2017-10-03T21:26:21-05:00
CRO Health Decisions Names Andrea Lukes, MD, FACOG, CMO
- CRO Health Decisions Announces Women’s Health Initiative Danielle Kroft 2017-10-03T21:26:02-05:00
CRO Health Decisions Announces Women’s Health Initiative
- ISSWSH-ISSM 2019 March 7 – 10, Atlanta, GA Danielle Kroft 2019-01-31T19:06:28-05:00
ISSWSH-ISSM 2019 March 7 – 10, Atlanta, GA
- Association for Molecular Pathology (AMP) 2018 Annual Meeting November 1 – 3, San Antonio, TX Danielle Kroft 2019-01-15T17:02:46-05:00
Association for Molecular Pathology (AMP) 2018 Annual Meeting November 1 – 3, San Antonio, TX
- American Society of Reproductive Medicine (ASRM) Scientific Congress & Expo 2018 October 6 – 10, Denver, CO Danielle Kroft 2017-12-12T18:29:54-05:00
American Society of Reproductive Medicine (ASRM) Scientific Congress & Expo 2018 October 6 – 10, Denver, CO
- Annual Meeting of the North American Menopause Society Oct 3 – 6, 2018, San Diego, CA Danielle Kroft 2017-12-13T14:30:50-05:00
Annual Meeting of the North American Menopause Society Oct 3 – 6, 2018, San Diego, CA
- Next Generation Dx Summit August 20 – 24, 2018, Washington, DC Danielle Kroft 2017-12-12T18:28:42-05:00
Next Generation Dx Summit August 20 – 24, 2018, Washington, DC
- American College of Obstetricians and Gynecologists 2019 Annual Clinical and Scientific Meeting May 3-6, Nashville, TN Danielle Kroft 2019-03-28T16:40:49-05:00
American College of Obstetricians and Gynecologists 2019 Annual Clinical and Scientific Meeting May 3-6, Nashville, TN
- Phase 2c: Expedited Development for All Danielle Kroft 2018-09-24T17:29:40-05:00
Phase 2c: Expedited Development for All
- Capabilities in Gastroenterology Studies Danielle Kroft 2017-10-03T21:37:27-05:00
Capabilities in Gastroenterology Studies
- Pivotal Study of an Alzheimer’s Drug Danielle Kroft 2017-10-03T21:37:17-05:00
Pivotal Study of an Alzheimer’s Drug
- Capabilities in Early Phase Studies Danielle Kroft 2017-10-03T21:35:28-05:00
Capabilities in Early Phase Studies
- Federal Contracting Capabilities Overview Danielle Kroft 2017-10-03T21:35:19-05:00
Federal Contracting Capabilities Overview
- 510(k) Study of a Respiratory Diagnostic Danielle Kroft 2018-08-23T14:44:36-05:00
510(k) Study of a Respiratory Diagnostic
- Perfecting Phase 2: Ten Essential Steps Danielle Kroft 2020-01-13T18:39:30-05:00
Perfecting Phase 2: Ten Essential Steps
- LiveTrial Data Management as a Service Danielle Kroft 2017-10-03T21:30:50-05:00
LiveTrial Data Management as a Service
- Ten Tips for Establishing the Clinical Utility of Molecular Diagnostics Danielle Kroft 2019-10-07T20:28:51-05:00
Ten Tips for Establishing the Clinical Utility of Molecular Diagnostics
- Nine Tips for Success in Precision Medicine Danielle Kroft 2018-03-28T21:32:57-05:00
Nine Tips for Success in Precision Medicine
- Addressing the New Imperative to Include Females in Clinical Trials Danielle Kroft 2019-01-24T19:02:10-05:00
Addressing the New Imperative to Include Females in Clinical Trials
- Large PMA Study of a Colorectal Cancer Diagnostic Danielle Kroft 2020-01-03T14:18:33-05:00
Large PMA Study of a Colorectal Cancer Diagnostic
- Capabilities in Women’s Health Studies Danielle Kroft 2018-08-23T14:51:02-05:00
Capabilities in Women’s Health Studies
- Capabilities for Clinical Studies in the Genitourinary Syndrome of Menopause (GSM) Danielle Kroft 2019-03-06T20:33:03-05:00
Capabilities for Clinical Studies in the Genitourinary Syndrome of Menopause (GSM)
- Diagnostics Development Services Danielle Kroft 2019-01-14T17:52:21-05:00
Diagnostics Development Services
- Case Study of a Bacterial Vaginosis Trial Danielle Kroft 2018-08-24T15:08:02-05:00
Case Study of a Bacterial Vaginosis Trial
- Capabilities for Clinical Studies in Contraception Danielle Kroft 2018-09-18T15:33:22-05:00
Capabilities for Clinical Studies in Contraception
- Capabilities for Clinical Studies in Osteoporosis Danielle Kroft 2018-08-23T20:18:19-05:00
Capabilities for Clinical Studies in Osteoporosis
- Dual 510(k)/CLIA Waiver Study of a POC Test Danielle Kroft 2020-01-13T19:47:48-05:00
Dual 510(k)/CLIA Waiver Study of a POC Test
- Capabilities for Clinical Studies in Female Sexual Dysfunction Danielle Kroft 2018-12-11T19:59:01-05:00
Capabilities for Clinical Studies in Female Sexual Dysfunction
- Capabilities for Clinical Studies in Endometriosis Danielle Kroft 2020-01-13T18:25:03-05:00
Capabilities for Clinical Studies in Endometriosis
- Considerations for Clinical Studies in Heavy Menstrual Bleeding Danielle Kroft 2018-12-12T18:31:49-05:00
Considerations for Clinical Studies in Heavy Menstrual Bleeding
- Considerations for Clinical Studies in Migraine Prophylaxis and Treatment Danielle Kroft 2018-12-13T15:49:48-05:00
Considerations for Clinical Studies in Migraine Prophylaxis and Treatment
- Considerations for Studies in Infectious Diseases of the Genitourinary System Danielle Kroft 2020-04-16T19:24:09-05:00
Considerations for Studies in Infectious Diseases of the Genitourinary System
- A Framework for Successful Pain Measurement in Clinical Trials Danielle Kroft 2020-01-13T16:43:16-05:00
A Framework for Successful Pain Measurement in Clinical Trials
- DSP Clinical Research and Health Decisions: Partners Accelerating Research in Reproductive Medicine Danielle Kroft 2020-01-13T16:03:06-05:00
DSP Clinical Research and Health Decisions: Partners Accelerating Research in Reproductive Medicine
Recent Tweets
- Webinar: Key Tips for Diagnostics in 2018 and Beyond – Development Success in the Evolving US and EU Landscape healthdec_rljyp3 2018-08-23T20:43:28-05:00
Webinar: Key Tips for Diagnostics in 2018 and Beyond – Development Success in the Evolving US and EU Landscape
- Webinar: Critical Success Factors in Reproductive Health Studies – Practical Tips for Minimizing Timelines, Risk and Costs healthdec_rljyp3 2018-08-23T20:40:49-05:00
Webinar: Critical Success Factors in Reproductive Health Studies – Practical Tips for Minimizing Timelines, Risk and Costs
- Webinar: Heavy Menstrual Bleeding – Medical Background and PI and Patient Perspectives on Clinical Trials healthdec_rljyp3 2018-08-23T20:39:43-05:00
Webinar: Heavy Menstrual Bleeding – Medical Background and PI and Patient Perspectives on Clinical Trials
- Is a Specialty CRO Right for You? healthdec_rljyp3 2018-08-22T18:32:39-05:00
Is a Specialty CRO Right for You?
